Evaluate Vantage’s 2021 in Review Infographic

Evaluate Vantage 2021 レビュー インフォグラフィック 英語版

Bringing you a snapshot of the critical themes from Evaluate Vantage’s 2021 in Review, this infographic touches on key business development decisions and financing deals in the world of pharma, biotech and medtech. 

In short – 2021 was a year of mixed signals.  


Download the infographic for data-driven insights on:

Biopharma’s biggest stock market winners and losers
Dramatic divergences in investment across the sector
Why it paid to be a private company
Why M&A was a mixed bag
How novel therapeutics reached new heights